Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Crossref DOI link: https://doi.org/10.1007/s10549-015-3656-0
Published Online: 2015-12-26
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Metzger-Filho, Otto
de Azambuja, Evandro
Procter, Marion
Krieguer, Magalie
Smith, Ian
Baselga, Jose
Cameron, David
Untch, Michael
Jackisch, Christian
Bell, Richard
Gianni, Luca
Goldhirsch, Aron
Piccart, Martine
Gelber, Richard D.
Text and Data Mining valid from 2015-12-26